Literature DB >> 8790217

Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.

A S Arbab1, K Koizumi, K Toyama, T Araki.   

Abstract

UNLABELLED: We investigated the kinetics, cellular uptake and intracellular distribution of 99mTc-tetrofosmin in tumor cell lines and compared them with those of 99mTc-MIBI and 201TI.
METHODS: At specific intervals after incubation with radiotracers, cellular uptake was determined. Cells were also treated with nigericin, carbonyl cyanide m-chloro-phenylhydrazone (CCCP) and ouabain to determine their effects on the uptake of the tracers.
RESULTS: Each tracer showed similar uptake kinetics in both cell lines, and a steady-state was maintained for at least 4 hr. Nigericin stimulated the uptake of both 99mTc-tetrofosmin and 99mTc-MIBI in HBL-2 cells, although it inhibited their uptake in SW-13 cells. Nigericin also inhibited 90% of 201TI uptake in both cell lines. Addition of CCCP caused 73%-97% release of accumulated 99mTc-MIBI from both cell lines with or without nigericin pretreatment, indicating that most of the accumulated 99mTc-MIBI was related to mitochondria. The effect of CCCP on accumulated 99mTc-tetrofosmin was less marked than that on 99mTc-MIBI in both cell lines, indicating that only a part of accumulated 99mTc-tetrofosmin, was related to mitochondria. Ouabain preincubation inhibited 74%-77% and 51%-53% of 201TI uptake in HBL-2 and SW-13 cells, respectively, as well as inhibited 22%-31% uptake of 99mTc-tetrofosmin in both HBL-2 and SW-13 cells. Uptake by the dead cells of either cell line was negligible for each tracer.
CONCLUSION: Technetium-99m-tetrofosmin uptake depends on both cell membrane and mitochondrial potentials. Only a small fraction of 99mTc-tetrofosmin accumulates inside the mitochondria, while most 99mTc-MIBI accumulates inside the mitochondria. Thallium-201 uptake is partly independent of the Na+, K+ pump.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790217

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

Review 1.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

2.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients.

Authors:  Radu Mihai; Fergus Gleeson; Ian D Buley; Derek E Roskell; Gregory P Sadler
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.

Authors:  L Kostakoglu; U Uysal; E Ozyar; F B Demirkazik; M Hayran; L Atahan; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1997-06

4.  Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism.

Authors:  Miju Cheon; Joon Young Choi; Jae-Hoon Chung; Ji Young Lee; Sook Kyung Cho; Jang Yoo; Soo Bin Park; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-08-19

5.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

Authors:  Jean-Luc Moretti; Nathalie Hauet; Meltem Caglar; Olivier Rebillard; Zeynep Burak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

Review 6.  Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.

Authors:  Giuseppe Madeddu; Angela Spanu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236

7.  Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.

Authors:  V Vallejos; C Balaña; M Fraile; Y Roussos; J Capellades; P Cuadras; R Ballester; A Ley; A Arellano; R Rosell
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

8.  Breast scintigraphy today: indications and limitations.

Authors:  Orazio Schillaci; John R Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-23       Impact factor: 9.236

9.  Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI.

Authors:  Tohoru Takeda; Jin Wu; Yuko Fumikura; Keiji Iida; Satoru Kawano; Iwao Yamaguchi; Yuji Itai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-20       Impact factor: 9.236

10.  The value of Tc-99m tetrofosmin in the imaging of pituitary adenomas.

Authors:  N Kurtulmus; C Turkmen; S Yarman; H Tokmak; A Mudun
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.